The Unique Challenges, Growth in the Business of Health-System Pharmacy
From market pressures to regulatory framework, Eric Tichy, PharmD, MBA, BCPS, FCCP, FAST, discussed growth in the business of health-system pharmacy and the challenges it has faced.
Pharmacists as the Authority on Ultra-High-Cost Drugs
Erin Fox, PharmD, MHA, BCPS, FASHP, joined Drug Topics to discuss ultra-high-cost drugs and the American Society of Health-System Pharmacists 2025 Pharmacy Forecast.
Team-Based Care Crucial in Addressing Workforce Shortages
Jonathan Watanabe, PharmD, MS, PhD, BCGP, discussed gaps within primary care in the context of the American Society of Health-System Pharmacists 2025 Pharmacy Forecast.
ASHP’s Outlook for the Pharmacy Profession in 2025
Joseph DiPiro, PharmD, FCCP, FAAAS, broke down the importance of the ASHP Pharmacy Forecast and the process in which its content is curated.
NCPA's New Consortium Exemplifies Preparedness in Community Pharmacy
The new initiative is a way for NCPA to proactively engage its network of community pharmacies during a potential public health crisis.
How Pharmacy Matches Perfectly With Nutrition
Known as “The Nutrition Pharmacist,” Sarah Gray, PharmD, GAICD, recently joined Drug Topics to discuss her dual profession within health care.
Breaking Down Return Solutions’ Rx Returns Process with Jeremy Cundiff
Jeremy Cundiff, PharmD, co-owner of Professional Pharmacy Group, joined Drug Topics to discuss Return Solutions and the company’s Rx Returns process.
Is LTC Pharmacy Going Back to the Future?
Drug Topics sat down with Sandra Canally, RN, founder and CEO of The Compliance Team, and Kara Benson, PharmD, long-term care director of Lewis Drug Inc, to discuss the future of LTC pharmacy.
RPhCast, Episode One: Statins, Blood Pressure, and Curves Galore
Listen to the first episode of RPHCast, where Kevin and Donna educate you on all things statins, blood pressure, cholesterol, and as many curves as you can imagine.
Episode 9: The "Disruptors" and the Role of Innovation in Drug Pricing
Eric Levin, CEO of Scripta Insights, discusses how "positive disruption" from private companies are positioned to confront challenges within the pharmaceutical industry.
